Rota PA, Moss WJ, Takeda M, De Swart RL, Thompson KM, Goodson JL, Measles. Nature Reviews Disease Primers 2016 2:1 [Internet]. 2016 Jul 14 [cited 2024 Jul 7];2(1):1–16. https://www.nature.com/articles/nrdp201649

Lee C, Robinson JL. Systematic review of the effect of immunization mandates on uptake of routine childhood immunizations. Journal of Infection [Internet]. 2016 Jun 1 [cited 2024 Jul 7];72(6):659–66. http://www.journalofinfection.com/article/S0163445316300299/fulltext

Jain R, Aulakh R, Measles-Associated CNS, Complications A, Review. J Child Sci [Internet]. 2022 [cited 2024 Jul 7];12:172–81. Available from: https://doi.org/.

Moss WJ, Measles. The Lancet [Internet]. 2017 Dec 2 [cited 2024 Jul 24];390(10111):2490–502. http://www.thelancet.com/article/S0140673617314630/fulltext

Costales C, Sahoo MK, Huang CH, Guimaraes CV, Born D, Kushner L et al. Vaccine-Associated Measles Encephalitis in Immunocompromised Child, California, USA. Emerg Infect Dis [Internet]. 2022 Apr 1 [cited 2024 Jul 24];28(4):906. /pmc/articles/PMC8962891/.

Fisher DL, Defres S, Solomon T. Measles-induced encephalitis. QJM: An International Journal of Medicine [Internet]. 2015 Mar 1 [cited 2024 Jul 24];108(3):177–82. https://doi.org/10.1093/qjmed/hcu113

Mogensen TH. Unexplored Roles of Type I Interferon in Antiviral Immunity and Regulation of Inflammation Revealed by Studying Patients With Inborn Errors of Immunity. Clinical Infectious Diseases [Internet]. 2022 Jan 7 [cited 2024 Jul 14];74(1):140–3. https://doi.org/10.1093/cid/ciaa1798

Duncan CJA, Mohamad SMB, Young DF, Skelton AJ, Leahy TR, Munday DC et al. Human IFNAR2 deficiency: lessons for antiviral immunity. Sci Transl Med [Internet]. 2015 Sep 9 [cited 2024 Jul 14];7(307):307ra154. /pmc/articles/PMC4926955/.

Passarelli C, Civino A, Rossi MN, Cifaldi L, Lanari V, Moneta GM et al. IFNAR2 Deficiency Causing Dysregulation of NK Cell functions and presenting with Hemophagocytic Lymphohistiocytosis. Front Genet. 2020;11.

Duncan CJA, Skouboe MK, Howarth S, Hollensen AK, Chen R, Børresen ML et al. Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the Arctic. J Exp Med [Internet]. 2022 Jun 6 [cited 2024 Jul 14];219(6). /pmc/articles/PMC9026249/.

Jouanguy E, Zhang SY, Chapgier A, Sancho-Shimizu V, Puel A, Picard C et al. Human primary immunodeficiencies of type I interferons. Biochimie [Internet]. 2007 Jun [cited 2024 Jul 24];89(6–7):878–83. https://pubmed.ncbi.nlm.nih.gov/17561326/

Ameratunga R, Longhurst H, Lehnert K, Steele R, Edwards ESJ, Woon ST. Are All Primary Immunodeficiency Disorders Inborn Errors of Immunity? Front Immunol [Internet]. 2021 Jul 21 [cited 2024 Aug 3];12. Available from: /pmc/articles/PMC8335567/.

McNab F, Mayer-Barber K, Sher A, Wack A, O’Garra A. Type I interferons in infectious disease. Nature Reviews Immunology. 2015 15:2 [Internet]. 2015 Jan 23 [cited 2024 Jul 14];15(2):87–103. https://www.nature.com/articles/nri3787

Adi G. Severe adverse reaction to Measles Vaccine due to homozygous mutation in IFNAR2 gene: a Case Report and Literature Review of IFNAR2 mutation in a. Ten-Month-Old Infant. 2024;1.

McCusker C, Upton J, Warrington R. Primary immunodeficiency. Allergy Asthma Clin Immunol [Internet]. 2018 Sep 12 [cited 2024 Jul 14];14(Suppl 2):61. /pmc/articles/PMC6157160/.

Mahlaoui N, Warnatz K, Jones A, Workman S, Cant A. Advances in the Care of Primary Immunodeficiencies (PIDs): from Birth to Adulthood. J Clin Immunol [Internet]. 2017 Jul 1 [cited 2024 Jul 14];37(5):452. /pmc/articles/PMC5489581/.

Jing H, Su HC. New Immunodeficiency syndromes that help us understand the IFN-mediated antiviral immune response. Curr Opin Pediatr [Internet]. 2019 Dec 1 [cited 2024 Jul 15];31(6):815. /pmc/articles/PMC6993897/.

Salem S, Langlais D, Lefebvre F, Bourque G, Bigley V, Haniffa M et al. Functional characterization of the human dendritic cell immunodeficiency associated with the IRF8K108E mutation. Blood [Internet]. 2014 Sep 18 [cited 2024 Jul 15];124(12):1894–904. https://doi.org/10.1182/blood-2014-04-570879

Salem S, Salem D, Gros P. Role of IRF8 in immune cells functions, protection against infections, and susceptibility to inflammatory diseases. Hum Genet [Internet]. 2020 Jun 1 [cited 2024 Jul 15];139(6–7):707–21. https://link.springer.com/article/https://doi.org/10.1007/s00439-020-02154-2

Sundararaj S, Casarotto MG. Molecular interactions of IRF4 in B cell development and malignancies. Biophys Rev [Internet]. 2021 Dec 1 [cited 2024 Jul 15];13(6):1219–27. https://link.springer.com/article/10.1007/s12551-021-00825-6

Hernandez N, Bucciol G, Moens L, Le Pen J, Shahrooei M, Goudouris E et al. Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines. Journal of Experimental Medicine [Internet]. 2019 Sep 2 [cited 2024 Aug 28];216(9):2057–70. https://doi.org/10.1084/jem.20182295

Zhang G, Deweerd NA, Stifter SA, Liu L, Zhou B, Wang W et al. A proline deletion in IFNAR1 impairs IFN-signaling and underlies increased resistance to tuberculosis in humans. Nature Communications 2017 9:1 [Internet]. 2018 Jan 8 [cited 2024 Aug 28];9(1):1–9. https://www.nature.com/articles/s41467-017-02611-z

Bastard P, Hsiao KC, Zhang Q, Choin J, Best E, Chen J et al. A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes. J Exp Med [Internet]. 2022 Jun 6 [cited 2024 Sep 5];219(6). /pmc/articles/PMC9026234/.

Hoyos-Bachiloglu R, Chou J, Sodroski CN, Beano A, Bainter W, Angelova M et al. A digenic human immunodeficiency characterized by IFNAR1 and IFNGR2 mutations. J Clin Invest [Internet]. 2017 Dec 1 [cited 2024 Jul 24];127(12):4415–20. https://doi.org/10.1172/JCI93486

Gothe F, Hatton CF, Truong L, Klimova Z, Kanderova V, Fejtkova M et al. A Novel Case of Homozygous Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency With Hemophagocytic Lymphohistiocytosis. Clinical Infectious Diseases [Internet]. 2022 Jan 7 [cited 2024 Aug 28];74(1):136–9. https://doi.org/10.1093/cid/ciaa1790

Khanmohammadi S, Rezaei N, Khazaei M, Shirkani A. A Case of Autosomal Recessive Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency with Severe COVID-19. J Clin Immunol [Internet]. 2022 Jan 1 [cited 2024 Aug 28];42(1):19–24. https://link.springer.com/article/10.1007/s10875-021-01166-5

Hernandez N, Melki I, Jing H, Habib T, Huang SSY, Danielson J et al. Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiency. Journal of Experimental Medicine [Internet]. 2018 Oct 1 [cited 2024 Sep 6];215(10):2567–85. https://doi.org/10.1084/jem.20180628

Gothe F, Stremenova Spegarova J, Hatton CF, Griffin H, Sargent T, Cowley SA et al. Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency. Journal of Allergy and Clinical Immunology [Internet]. 2022 Oct 1 [cited 2024 Sep 6];150(4):955–964.e16. http://www.jacionline.org/article/S0091674922001853/fulltext

Huber M, Suprunenko T, Ashhurst T, Marbach F, Raifer H, Wolff S et al. IRF9 Prevents CD8 + T Cell Exhaustion in an Extrinsic Manner during Acute Lymphocytic Choriomeningitis Virus Infection. J Virol [Internet]. 2017 Nov 15 [cited 2024 Sep 6];91(22):1219–36. https://journals.asm.org/doi/10.1128/jvi.01219-17

Hanrath AT, Hatton CF, Gothe F, Browne C, Vowles J, Leary P, et al. Type I interferon receptor (IFNAR2) deficiency reveals Zika virus cytopathicity in human macrophages and microglia. Front Immunol. 2022;13:1035532.

Article  CAS  PubMed  PubMed Central  Google Scholar 

López-Bielma MF, Falfán-Valencia R, Abarca-Rojano E, Pérez-Rubio G. Participation of Single-Nucleotide Variants in IFNAR1 and IFNAR2 in the Immune Response against SARS-CoV-2 Infection: A Systematic Review. Pathogens 2023, Vol 12, Page 1320 [Internet]. 2023 Nov 6 [cited 2024 Jul 17];12(11):1320. https://www.mdpi.com/2076-0817/12/11/1320/htm.

Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol [Internet]. 2014 Jan [cited 2024 Sep 6];14(1):36. /pmc/articles/PMC4084561/.

van der Made CI, Netea MG, van der Veerdonk FL, Hoischen A. Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19. Genome Medicine. 2022 14:1 [Internet]. 2022 Aug 19 [cited 2024 Jul 17];14(1):1–22. https://genomemedicine.biomedcentral.com/articles/https://doi.org/10.1186/s13073-022-01100-3

Sugrue JA, Bourke NM, O’Farrelly C. Type I Interferon and the Spectrum of susceptibility to viral infection and Autoimmune Disease: A Shared genomic signature. Front Immunol [Internet]. 2021 Nov 30 [cited 2024 Jul 17];12:757249. Available from: www.frontiersin.org.

Lurie RH, Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nature Reviews Immunology 2005 5:5 [Internet]. 2005 May [cited 2024 Jul 17];5(5):375–86. https://www.nature.com/articles/nri1604

Lee AJ, Ashkar AA. The dual nature of type I and type II interferons. Front Immunol [Internet]. 2018 Sep 11 [cited 2024 Jul 17];9(SEP):403701. Available from: www.frontiersin.org.

Stanifer ML, Guo C, Doldan P, Boulant S. Importance of type I and III interferons at respiratory and intestinal barrier surfaces. Front Immunol [Internet]. 2020;11:608645. Available from: https://doi.org/10.3389/fimmu.2020.608645

Mogensen TH, IRF, Transcription Factors STAT. - From Basic Biology to Roles in Infection, Protective Immunity, and Primary Immunodeficiencies. Front Immunol [Internet]. 2018 [cited 2024 Jul 17];9(JAN):3047. /pmc/articles/PMC6331453/.

Hervas-Stubbs S, Perez-Gracia JL, Rouzaut A, Sanmamed MF, Le Bon A, Melero I. Direct effects of type I interferons on cells of the immune system. Clinical Cancer Research [Internet]. 2011 May 1 [cited 2024 Jul 17];17(9):2619–27. /clincancerres/article/17/9/2619/12936/Direct-Effects-of-Type-I-Interferons-on-Cells-of.

Liang Y, Hannan R, Fu YX. Type I IFN activating type I dendritic cells for antitumor immunity. Clinical Cancer Research [Internet]. 2021 Jul 15 [cited 2024 Jul 17];27(14):3818–24. /clincancerres/article/27/14/3818/671521/Type-I-IFN-Activating-Type-I-Dendritic-Cells-for.

Zanin N, Viaris de Lesegno C, Lamaze C, Blouin CM. Interferon receptor trafficking and signaling: Journey to the Cross Roads. Front Immunol [Internet]. 2021;11:615603. Available from: https://doi.org/10.3389/fimmu.2020.615603

Smieszek SP, Polymeropoulos VM, Xiao C, Polymeropoulos CM, Polymeropoulos MH. Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility. J Glob Antimicrob Resist [Internet]. 2021 Sep 1 [cited 2024 Jul 17];26:239. /pmc/articles/PMC8279933/.

Pairo-Castineira E, Clohisey S, Klaric L, Bretherick AD, Rawlik K, Pasko D et al. Genetic mechanisms of critical illness in COVID-19. Nature 2020 591:7848 [Internet]. 2020 Dec 11 [cited 2024 Jul 24];591(7848):92–8. https://www.nature.com/articles/s41586-020-03065-y

Bastard P, Michailidis E, Hoffmann HH, Chbihi M, Le Voyer T, Rosain J et al. Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine. J Exp Med [Internet]. 2021 Apr 4 [cited 2024 Aug 28];218(4). /pmc/articles/PMC7871457/.

Frodsham AJ, Zhang L, Dumpis U, Taib NAM, Best S, Durham A et al. Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. Proc Natl Acad Sci U S A [Internet]. 2006 Jun 13 [cited 2024 Jul 17];103(24):9148–53. https://pubmed.ncbi.nlm.nih.gov/16757563/